Yoshio Takesue

5.5k total citations
222 papers, 3.4k citations indexed

About

Yoshio Takesue is a scholar working on Surgery, Infectious Diseases and Epidemiology. According to data from OpenAlex, Yoshio Takesue has authored 222 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 87 papers in Surgery, 78 papers in Infectious Diseases and 76 papers in Epidemiology. Recurrent topics in Yoshio Takesue's work include Antimicrobial Resistance in Staphylococcus (49 papers), Inflammatory Bowel Disease (38 papers) and Antibiotics Pharmacokinetics and Efficacy (30 papers). Yoshio Takesue is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (49 papers), Inflammatory Bowel Disease (38 papers) and Antibiotics Pharmacokinetics and Efficacy (30 papers). Yoshio Takesue collaborates with scholars based in Japan, United States and Kenya. Yoshio Takesue's co-authors include Hiroki Ikeuchi, Motoi Uchino, Yoshiko Takahashi, Kazuhiko Nakajima, Toshie Tsuchida, Takashi Yokoyama, Naohiro Tomita, Toshihiro Bando, Hiroshige Mikamo and Kazuaki Matsumoto and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Yoshio Takesue

207 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yoshio Takesue Japan	32	1.5k	1.1k	1.0k	834	559	222	3.4k
Riccardo Utili Italy	34	913 0.6×	2.7k 2.4×	731 0.7×	574 0.7×	343 0.6×	145	4.8k
Heinz Burgmann Austria	34	865 0.6×	1.5k 1.3×	554 0.5×	618 0.7×	281 0.5×	202	4.0k
Jennifer Han United States	26	547 0.4×	838 0.8×	311 0.3×	465 0.6×	393 0.7×	118	2.9k
K. V. I. Rolston United States	34	1.0k 0.7×	1.5k 1.4×	319 0.3×	501 0.6×	631 1.1×	86	3.5k
June Myung Kim South Korea	32	876 0.6×	1.2k 1.1×	546 0.5×	220 0.3×	378 0.7×	202	3.6k
P. Berthelot France	36	997 0.7×	1.7k 1.5×	781 0.8×	148 0.2×	317 0.6×	207	4.7k
Young Goo Song South Korea	31	921 0.6×	1.3k 1.2×	577 0.6×	265 0.3×	324 0.6×	220	3.3k
Elio Castagnola Italy	40	2.6k 1.7×	3.0k 2.7×	461 0.5×	776 0.9×	863 1.5×	300	6.6k
Manel Almela Spain	36	2.3k 1.5×	2.3k 2.1×	588 0.6×	425 0.5×	1.4k 2.5×	111	4.3k
G. K. M. Harding Canada	39	753 0.5×	2.5k 2.3×	419 0.4×	760 0.9×	683 1.2×	110	4.4k

Countries citing papers authored by Yoshio Takesue

Since Specialization

Citations

This map shows the geographic impact of Yoshio Takesue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yoshio Takesue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yoshio Takesue more than expected).

Fields of papers citing papers by Yoshio Takesue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yoshio Takesue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yoshio Takesue. The network helps show where Yoshio Takesue may publish in the future.

Co-authorship network of co-authors of Yoshio Takesue

This figure shows the co-authorship network connecting the top 25 collaborators of Yoshio Takesue. A scholar is included among the top collaborators of Yoshio Takesue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yoshio Takesue. Yoshio Takesue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Otani, Naruhito, Kazuhiko Nakajima, Kumiko Yamada, et al.. (2024). Timing of Assessment of Humoral and Cell-Mediated Immunity after Influenza Vaccination. Vaccines. 12(6). 584–584.

Murakami, Yasushi, et al.. (2024). Difference in the impact of coinfections and secondary infections on antibiotic use in patients hospitalized with COVID-19 between the Omicron-dominant period and the pre-Omicron period. Journal of Infection and Chemotherapy. 30(9). 853–859. 1 indexed citations

Oda, Kazutaka, Kazuaki Matsumoto, Akari Shigemi, et al.. (2024). Validation and development of population pharmacokinetic model of vancomycin using a real-world database from a nationwide free web application. Journal of Infection and Chemotherapy. 30(12). 1244–1251. 1 indexed citations

Takada, Keisuke, Naoki Hirose, Fumio Nagumo, et al.. (2023). Comparison of the efficacy and safety of standard‐ and high‐dose daptomycin: A systematic review and meta‐analysis. British Journal of Clinical Pharmacology. 89(4). 1291–1303. 4 indexed citations

Hanai, Yuki, Takashi Ueda, Yukihiro Hamada, et al.. (2023). Optimal timing for therapeutic drug monitoring of voriconazole to prevent adverse effects in Japanese patients. Mycoses. 66(12). 1035–1044. 6 indexed citations

Otani, Naruhito, Masayuki Shima, Takashi Ueda, et al.. (2023). Changes in the Epidemiology of Rubella: The Influence of Vaccine-Introducing Methods and COVID-19. Vaccines. 11(8). 1358–1358. 4 indexed citations

Matsumoto, Kazuaki, Kazutaka Oda, Kensuke Shoji, et al.. (2022). Clinical Practice Guidelines for Therapeutic Drug Monitoring of Vancomycin in the Framework of Model-Informed Precision Dosing: A Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Pharmaceutics. 14(3). 489–489. 78 indexed citations

Takesue, Yoshio, Yuki Hanai, Kazutaka Oda, et al.. (2022). Clinical Practice Guideline for the Therapeutic Drug Monitoring of Voriconazole in Non-Asian and Asian Adult Patients: Consensus Review by the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. Clinical Therapeutics. 44(12). 1604–1623. 37 indexed citations

Ueda, Takashi, Yoshio Takesue, Kazuhiko Nakajima, et al.. (2022). Validation of Vancomycin Area under the Concentration—Time Curve Estimation by the Bayesian Approach Using One-Point Samples for Predicting Clinical Outcomes in Patients with Methicillin-Resistant Staphylococcus aureus Infections. Antibiotics. 11(1). 96–96. 21 indexed citations

10.

Hanai, Yuki, Yukihiro Hamada, Toshimi Kimura, et al.. (2021). Favorable Effects of Voriconazole Trough Concentrations Exceeding 1 μg/mL on Treatment Success and All-Cause Mortality: A Systematic Review and Meta-Analysis. Journal of Fungi. 7(4). 306–306. 24 indexed citations

11.

Hanai, Yuki, Yoshiko Takahashi, Takashi Niwa, et al.. (2021). Optimal trough concentration of teicoplanin for the treatment of methicillin‐resistant Staphylococcus aureus infection: A systematic review and meta‐analysis. Journal of Clinical Pharmacy and Therapeutics. 46(3). 622–632. 17 indexed citations

12.

Hanai, Yuki, Yukihiro Hamada, Toshimi Kimura, et al.. (2020). Optimal trough concentration of voriconazole with therapeutic drug monitoring in children: A systematic review and meta-analysis. Journal of Infection and Chemotherapy. 27(2). 151–160. 20 indexed citations

13.

Mikamo, Hiroshige, Yoshio Takesue, Y. Iwamoto, et al.. (2018). Efficacy, safety and pharmacokinetics of tedizolid versus linezolid in patients with skin and soft tissue infections in Japan – Results of a randomised, multicentre phase 3 study. Journal of Infection and Chemotherapy. 24(6). 434–442. 42 indexed citations

14.

Takahashi, Yoshiko, et al.. (2017). Risk factors associated with unexpectedly high trough concentration and the occurrence of nephrotoxicity in patients with vancomycin treatment. The Journal of Antibiotics. 70(3). 143–154. 2 indexed citations

15.

Uchino, Motoi, et al.. (2016). Randomized Controlled Trial of Prophylactic Negative-Pressure Wound Therapy at Ostomy Closure for the Prevention of Delayed Wound Healing and Surgical Site Infection in Patients with Ulcerative Colitis. Digestive Surgery. 33(6). 449–454. 33 indexed citations

16.

Tsuchida, Toshie, Yoshio Takesue, Kaoru Ichiki, et al.. (2016). Influence of Peri-Operative Hypothermia on Surgical Site Infection in Prolonged Gastroenterological Surgery. Surgical Infections. 17(5). 570–576. 27 indexed citations

17.

Takesue, Yoshio, Hiroshige Mikamo, Shinya Kusachi, et al.. (2015). Correlation between pharmacokinetic/pharmacodynamic indices and clinical outcomes in Japanese patients with skin and soft tissue infections treated with daptomycin: analysis of a phase III study. Diagnostic Microbiology and Infectious Disease. 83(1). 77–81. 9 indexed citations

18.

Takesue, Yoshio, Yusuke Tanigawara, Hiroshige Mikamo, et al.. (2010). Therapeutic drug monitoring survey of anti-MRSA agents in Japan. 58(2). 119–124. 4 indexed citations

19.

Iwata, Satoshi, Hiromi Kumon, Yoshihito Niki, et al.. (2007). Survey on once-daily therapy with ceftriaxone for pediatric bacterial infections. 55(6). 463–472. 1 indexed citations

20.

Fujita, Atsushi, et al.. (2001). Vitreous hemorrhage in a case of acute myeloblastic leukemia. 55(5). 909–912. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact